PR Newswire: news distribution, targeting and monitoring
2014
See more news releases in Medical Pharmaceuticals

Cardiome to Present at Oppenheimer Healthcare Conference

Share with Twitter Share with LinkedIn

NASDAQ: CRME   TSX: COM

VANCOUVER, Nov. 1 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Doug Janzen, President and CEO, is scheduled to present an overview of Cardiome at the 21st Annual Oppenheimer Healthcare Conference in New York on Tuesday, November 2, 2010 at 3:20pm Eastern (12:20pm Pacific). 

A live webcast of Mr. Janzen's presentation can be accessed on Cardiome's website at www.cardiome.com. A replay of the webcast will be posted after the presentation and will be available until December 2, 2010.

About Cardiome Pharma Corp.

Cardiome Pharma Corp. is a product-focused drug development company dedicated to the advancement and commercialization of novel treatments for disorders of the heart and circulatory system.  Cardiome is traded on the NASDAQ Global Market (CRME) and the Toronto Stock Exchange (COM).  For more information, please visit our web site at www.cardiome.com.

SOURCE Cardiome Pharma Corp.



Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release